David Malcom Rodman
Chief Medical Officer · 15 filings · Latest: Jun 15, 2026
Mineralys Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MLYS | David Malcom Rodman | Chief Medical Officer | Jan 20, 2026 | Option Exercise | $15.44 | 416 | $6.4K | 50,853 | |
MLYS | Rodman David Malcom | — | Jan 20, 2026 | Proposed Sale | $32.10 | 416 | $13.4K | — | |
MLYS | Rodman David Malcom | — | Jan 14, 2026 | Proposed Sale | $32.61 | 11,367 | $370.6K | — | |
MLYS | Rodman David Malcom | — | Jan 13, 2026 | Proposed Sale | $32.75 | 7,709 | $252.5K | — | |
MLYS | Rodman David Malcom | — | Jan 12, 2026 | Proposed Sale | $32.32 | 6,348 | $205.1K | — | |
MLYS | Rodman David Malcom | — | Jan 9, 2026 | Proposed Sale | $33.27 | 2,170 | $72.2K | — | |
MLYS | Rodman David Malcom | — | Jan 2, 2026 | Proposed Sale | $35.71 | 262,752 | $9.4M | — | |
MLYS | Rodman David Malcom | — | Oct 15, 2025 | Proposed Sale | $43.01 | 10,369 | $446.0K | — | |
MLYS | Rodman David Malcom | — | Sep 15, 2025 | Proposed Sale | $36.00 | 11,367 | $409.3K | — | |
MLYS | Rodman David Malcom | — | Aug 13, 2025 | Proposed Sale | $12.93 | 11,365 | $147.0K | — | |
MLYS | Rodman David Malcom | — | Jul 14, 2025 | Proposed Sale | $14.59 | 11,366 | $165.9K | — | |
MLYS | Rodman David Malcom | — | Jun 13, 2025 | Proposed Sale | $14.60 | 11,366 | $165.9K | — | |
MLYS | Rodman David Malcom | — | May 14, 2025 | Proposed Sale | $15.29 | 11,366 | $173.8K | — | |
MLYS | Rodman David Malcom | — | Apr 14, 2025 | Proposed Sale | $14.53 | 11,366 | $165.2K | — | |
MLYS | Rodman David Malcom | — | Apr 1, 2025 | Proposed Sale | $15.76 | 55,771 | $879.0K | — | |
MLYS | Rodman David Malcom | — | Nov 6, 2024 | Proposed Sale | $15.03 | 25,482 | $383.1K | — | |
MLYS | Rodman David Malcom | — | Nov 11, 2024 | Proposed Sale | $15.00 | 5,026 | $75.4K | — |
← Previous
Page 4 of 4